Recent Synthetic and Biological Developments on 1,2,4‐Triazolopyrimidines
ChemistrySelect · 05.09.2023 · 8 (33)
DOI: 10.1002/slct.202301534 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 04.09.2023. Verfasst von Parul Kaushik und 4 weiteren Autor:innen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 123 Literaturangaben.
Abstract (Originalsprache)
1,2,4‐Triazolopyrimidines scaffold spaciously acknowledged with anticancer, antimalarial, antitubercular and many other fascinating biological applications in recent years (2015–2022). Moreover, numerous mild synthetic methodologies reported, which has been summarized as (i) condensation of 2‐amino‐1,2,4‐triazole or 5‐amino‐1,2,4‐triazole with 1,3‐dielectrophilic equivalents like 1,3‐diketones, β‐ketoester (ii) oxidative‐cyclization of hydrazones or related analogues. This review would flourish the synthetic and medicinal chemist to design more bioactive 1,2,4‐triazolopyrimidines molecules for drug development with enhanced binding interactions, structural features with the help discussed SAR and cost effective methodologies in the coming years.
Zitieren
APA
Kaushik, P., Kumar, R., Khokhar, S., Dhiman, S., & Kamal, R. (2023). Recent Synthetic and Biological Developments on 1,2,4‐Triazolopyrimidines. ChemistrySelect, 8(33). https://doi.org/10.1002/slct.202301534
Vancouver
Kaushik P, Kumar R, Khokhar S, Dhiman S, Kamal R. Recent Synthetic and Biological Developments on 1,2,4‐Triazolopyrimidines. ChemistrySelect. 2023;8(33). doi:10.1002/slct.202301534
BibTeX
@article{Kaushik2023,
author = {Kaushik, Parul and Kumar, Ravinder and Khokhar, Shiwani and Dhiman, Sukhvinder and Kamal, Raj},
title = {Recent Synthetic and Biological Developments on 1,2,4‐Triazolopyrimidines},
journal = {ChemistrySelect},
year = {2023},
volume = {8},
number = {33},
doi = {10.1002/slct.202301534}
}
EUVIMED